Skip to main content
Equibles

Thrivent Financial for Lutherans

Position in FATE — Fate Therapeutics Inc

CIK 314984 Minneapolis, MN
Back to FATE Full portfolio

Position in FATE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$92,082
+$51,157 QoQ
Shares Held
34,105
0.0% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#75
of 156 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FATE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Thrivent Financial for Lutherans holds $496,588,000 across 51 Biotechnology names. FATE ranks #49 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TWST
Twist Bioscience Corp
 1,433,503 $147,478,787
2 EXEL
Exelixis, Inc.
 1,620,743 $88,184,625
3 REGN
Regeneron Pharmaceuticals, Inc.
 131,457 $81,968,697
4 RPRX
Royalty Pharma plc
 740,772 $41,535,085
5 JAZZ
Jazz Pharmaceuticals plc
 80,500 $19,398,084
6 ARGX
Argenx SE
 12,688 $11,771,545
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 20,169 $10,018,546
8 VCEL
Vericel Corp
 170,272 $7,575,400

All Filings in FATE

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $92,082 34,105
2026-03-31 $40,925 34,105
2025-12-31 $33,422 34,105
2025-09-30 $42,972 34,105
2025-06-30 $41,569 37,116
2025-03-31 $70,564 89,322
2024-12-31 $147,381 89,322
2024-09-30 $438,795 125,370
2024-06-30 $329,856 100,566